- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 159-173 of
397 results
1004 Exhibit: US Serial Number 11083,167, Amendment and Response, Oct 5, 200...
Document
IPR2018-00943, No. 1004-4 Exhibit - US Serial Number 11083,167, Amendment and Response, Oct 5, 2009 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1009 Exhibit: US Serial Number 11083,167, Notice of Allowance, Dec 1, 2010
Document
IPR2018-00943, No. 1009-9 Exhibit - US Serial Number 11083,167, Notice of Allowance, Dec 1, 2010 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1042 Exhibit: Orange Book Approved Drug Products with Therapeutic Equivalence...
Document
IPR2018-00943, No. 1042-37 Exhibit - Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1031 Exhibit: CV of Dr Park
Document
IPR2018-00943, No. 1031-55 Exhibit - CV of Dr Park (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1025 Exhibit: Chiang et al, Kinetics of a naltrexone sustained release preparation, 3...
Document
IPR2018-00943, No. 1025-23 Exhibit - Chiang et al, Kinetics of a naltrexone sustained release preparation, 365 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1033 Exhibit: Manit Srisurapanont Ngamwong Jarusuraisin
Document
IPR2018-00943, No. 1033-28 Exhibit - Manit Srisurapanont Ngamwong Jarusuraisin (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1006 Exhibit: US Serial Number 11083,167, Amendment and Response, Apr 5, 201...
Document
IPR2018-00943, No. 1006-6 Exhibit - US Serial Number 11083,167, Amendment and Response, Apr 5, 2010 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1046 Exhibit: Riddle et al, Anxiolytics, adrenergic agents, and naltrexone
Document
IPR2018-00943, No. 1046-41 Exhibit - Riddle et al, Anxiolytics, adrenergic agents, and naltrexone (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1035 Exhibit: JS Hopkins et al, Naltrexone and Acamprosate Meta Anaylsis of Two ...
Document
IPR2018-00943, No. 1035-30 Exhibit - JS Hopkins et al, Naltrexone and Acamprosate Meta Anaylsis of Two Medical Treatments for Alcoholism (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1060 Exhibit: WayBack Machine capture of Security and Exchange Commissions R...
Document
IPR2018-00943, No. 1060-62 Exhibit - WayBack Machine capture of Security and Exchange Commissions Regulator Overview of the Electronic Data Gathering, Analysis, and Retrieval System E...
|
|
Cite Document
1015 Exhibit: US Patent No 6,306,425
Document
IPR2018-00943, No. 1015-15 Exhibit - US Patent No 6,306,425 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1045 Exhibit: Guidance for Industry Bioavailability and Bioequivalence Studies for ...
Document
IPR2018-00943, No. 1045-40 Exhibit - Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Products (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1026 Exhibit: Reuning et al, Pharmacokinetic Quantitation of Naltrexone Release F...
Document
IPR2018-00943, No. 1026-24 Exhibit - Reuning et al, Pharmacokinetic Quantitation of Naltrexone Release From Several Sustained Release Delivery Systems (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1057 Exhibit: US Patent No 3,332,950
Document
IPR2018-00943, No. 1057-52 Exhibit - US Patent No 3,332,950 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1024 Exhibit: US Patent No 4,882,335
Document
IPR2018-00943, No. 1024-22 Exhibit - US Patent No 4,882,335 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
